Vitamin E containing polymer micelles for reducing normal cell cytotoxicity and enhancing chemotherapy efficacy

Acta Biomater. 2015 Sep:24:286-96. doi: 10.1016/j.actbio.2015.06.014. Epub 2015 Jun 16.

Abstract

An α-tocopheryl succinate (α-TOS) containing diblock copolymer micellar system was used to deliver doxorubicin (Dox), an anticancer drug, for HCT116 colon cancer therapy. The α-TOS containing diblock copolymers were synthesized by conjugation of α-TOS molecules and a mPEG-b-PHEMA hydrophilic diblock copolymer by ester bonds. The Dox-loaded polymeric micelles were then obtained by solvent exchange process. In acidic surroundings such as endosomes or secondary lysosomes, the structures of the Dox-loaded polymeric micelles deformed and released the drug loads. Additionally, Dox-loaded polymeric micelles enhanced the cytotoxicity of Dox and α-TOS to cancer cells in vitro. Dox-loaded polymeric micelles also showed an exceptional tumor inhibiting effect in vivo. This study indicates that the α-TOS containing polymeric micelle system can be used as a drug carrier for cancer therapy.

Keywords: Cancer therapy; Doxorubicin; Intracellular drug delivery; Micelles; α-Tocopheryl succinate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Doxorubicin* / chemistry
  • Doxorubicin* / pharmacology
  • Drug Carriers* / chemistry
  • Drug Carriers* / pharmacology
  • Humans
  • Mice
  • Micelles*
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • alpha-Tocopherol* / chemistry
  • alpha-Tocopherol* / pharmacology

Substances

  • Drug Carriers
  • Micelles
  • Doxorubicin
  • alpha-Tocopherol